The Ledger · 2 issues
Skincare journalism,
on the record.
The Ledger is where Uwazia takes positions. Long-form essays on actives, regulation, melanin-rich biology, and the brands shaping the industry — read from primary literature, written without hype. No sponsored copy. No affiliate links. No “skincare is complicated.”
For informational purposes only. For medical advice or a diagnosis, consult a professional.
What you’ll find here
Investigative pieces that read primary literature, regulatory filings, and clinical trial registries — then translate the findings into actionable label-reading guidance. Each article addresses melanin-rich phototypes specifically when the science diverges.
Issues
Read.
- № 02
Concentration
The Saturation Paradox
Why 10% niacinamide is a marketing construct, not a clinical superiority.
Receptor saturation, the PAR-2 ceiling, and the clinical case for 2–5% niacinamide — especially for Fitzpatrick IV–VI skin.
May 16, 202611 min readRead - № 01
Regulation
The Hydroquinone Paradox
Structural failure, regulatory shifts, and the rise of precision tyrosinase inhibition
The FDA quietly banned over-the-counter hydroquinone in 2020. Three years later, half the dermatology offices in the US still hand it out off-label. Here's why the ban happened and what's actually working in its place.
May 15, 20268 min readRead
In development
Drafting next.
- № 01
Pigmentation
The melasma protocol
Triple combination therapy, the rise of tranexamic acid, and what the evidence says about each route.
- № 02
Sunscreen
Why US sunscreens lag a decade
Bemotrizinol, bisoctrizole, Tinosorb — the filters Asia and the EU have had for years that Americans still can't buy.
- № 03
Label literacy
Reading an INCI list
How to spot filler ingredients, fragrance hiding spots, and the 1% line — without a chemistry degree.
- № 04
Phototype
Sunscreen the studies forgot
Why most SPF research is run on Fitzpatrick I–III skin, and what that means if you're IV–VI.
Subscribe to the Ledger
Each issue, in your inbox.
One email per issue. No marketing copy, no affiliate links, no other lists. We won’t share the address. Unsubscribe in one click.